Drug Trial Radar · NCT05436652
A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
Last checked: Nov 19, 2026Latest source record: May 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
66
Actual
Start
Jul 22, 2022
Primary completion
Apr 25, 2025
Study completion Apr 25, 2025
Sponsor
- Lead sponsor
- Sparrow PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jun 29, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This will be a single-blind, placebo-controlled phase 2 trial to compare prednisolone effects with and without SPI-62 in participants with PMR.
Conditions
- Polymyalgia Rheumatica
Interventions
SPI-62Drug
11β hydroxysteroid dehydrogenase type 1 (HSD-1) inhibitor
SPI-62 matched placeboDrug
Inactive tablets identical in appearance to SPI-62 tablets
Prednisolone 10mgDrug
Standard of care prednisolone
Additional prednisoloneDrug
Over encapsulated prednisolone
Additional prednisolone matched placeboDrug
Inactive capsules identical in appearance to over encapsulated prednisolone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Erythrocyte sedimentation rateTime frame: Baseline to Day 28
- C-reactive proteinTime frame: Baseline to Day 28
- Plasma fibrinogenTime frame: Baseline to Day 28
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und klinische Immunologie
Berlin, Germany
Internistische Praxisgemeinschaft Rheumatologie Nephrologie
Erlangen, Germany
Hamburger Rheuma Forschungszentrum II im MVZ für Rheumatologie und Autoimmunmedizin
Hamburg, Germany
Katholische Kliniken Rhein-Ruhr am Marien Hospital, Universitätsklinik der Ruhr-Universität
Herne, Germany
Universitätsmedizin der Johannes Gutenberg Universität Mainz
Mainz, Germany
Praxis Prof. Dr. med. Herbert Kellner
Munich, Germany
NovaReuma
Bialystok, Poland
The University of Gdańsk
Gdansk, Poland
MICS Centrum Medyczne Warszawa
Warsaw, Poland
Dolnośląski Szpital Specjalistyczny im. T. Marciniaka
Wroclaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.